ABSTRACT
Se ha descrito un nuevo síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2. Este cuadro presenta una expresividad clínica variable y se asocia a infección activa o reciente por SARS-CoV-2. En este documento se revisa la literatura existente por parte de un grupo multidisciplinar de especialistas pediátricos. Posteriormente, se realizan recomendaciones sobre estabilización, diagnóstico y tratamiento de este síndrome
A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this síndrome
Subject(s)
Humans , Child , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Systemic Inflammatory Response Syndrome/complications , Consensus , Diagnosis, Differential , Systemic Inflammatory Response Syndrome/prevention & control , Hospitalization , BetacoronavirusABSTRACT
A 4-year-old child of 10 kg weight, with four previous sternotomies, presented a severe right heart failure, due to a severe regurgitation of his bioprosthetic tricuspid valve. A percutaneous tricuspid valve in valve procedure with an Edwards S3 valve was offered for compassionate use, and performed, with no complications, and significant clinical condition improvement.
Subject(s)
Bioprosthesis , Heart Valve Prosthesis Implantation , Heart Valve Prosthesis , Tricuspid Valve Insufficiency , Bioprosthesis/adverse effects , Cardiac Catheterization , Child, Preschool , Heart Valve Prosthesis/adverse effects , Humans , Prosthesis Design , Prosthesis Failure , Treatment Outcome , Tricuspid Valve/diagnostic imaging , Tricuspid Valve/surgery , Tricuspid Valve Insufficiency/diagnosis , Tricuspid Valve Insufficiency/surgeryABSTRACT
A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this syndrome.
Subject(s)
COVID-19/diagnosis , COVID-19/therapy , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/therapy , Algorithms , Child , HumansABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Infant, Newborn , Ductus Arteriosus/surgery , Heart Defects, Congenital/surgery , Stents , Heart-Assist Devices , Retrospective Studies , Treatment OutcomeABSTRACT
We implanted two sinus Superflex DS© stents in a systemic non-stenotic arterial duct of a newborn with hypoplastic left heart syndrome. Forty-eight hours later an important collapse of the stent was detected and treated with a balloon expandable stent. Sinus Superflex DS© has been specifically designed for systemic ducts. This complication generates doubts about its radial force in this scenario.
Subject(s)
Ductus Arteriosus/surgery , Hypoplastic Left Heart Syndrome/surgery , Prosthesis Failure , Stents/adverse effects , Angiography , Cardiac Surgical Procedures/instrumentation , Humans , Infant, Newborn , Male , Pulmonary Artery/surgery , Treatment OutcomeABSTRACT
No disponible
Subject(s)
Humans , Female , Adolescent , Vascular Closure Devices , Heart Septal Defects, Atrial/surgery , Coronary Sinus/abnormalities , Liver Transplantation , Treatment Outcome , Coronary Angiography/methodsSubject(s)
Cardiac Surgical Procedures/methods , Coronary Sinus/abnormalities , Coronary Vessel Anomalies/surgery , Adolescent , Coronary Angiography , Coronary Sinus/diagnostic imaging , Coronary Sinus/surgery , Coronary Vessel Anomalies/diagnosis , Echocardiography, Transesophageal , Female , Humans , Magnetic Resonance Imaging, Cine/methodsABSTRACT
Introducció: Les arrítmies ventriculars en l'edat pediàtrica poden presentar-se des de formes asimptomàtiques amb extrasístoles ventriculars aïllades fins a formes amb taquicàrdia ventricular sostinguda amb insuficiència i aturada cardíaques. La taquicàrdia ventricular idiopàtica infantil és una de les entitats clíniques dins d'aquest grup, amb unes característiques clíniques i de pronòstic diferenciades, i amb una evolució generalment benigna. Observació clínica: Presentem dos casos clínics neonatals amb taquicàrdia ventricular idiopàtica infantil. Tots dos van debutar en forma de taquicàrdia ventricular ben tolerada hemodinàmicament, però donada la freqüència d'aparició dels episodis es va decidir iniciar tractament antiarrítmic amb propranolol i, posteriorment, flecaïnida. En tots dos casos, al cap de 24-48 hores d'introducció de la flecaïnida es va observar un canvi a ritme sinusal i desaparició dels episodis de taquicàrdia ventricular. En el seguiment posterior no van presentar nous episodis arrítmics. Comentaris: El reconeixement de les característiques clíniques i electrocardiogràfiques és essencial per fer un diagnòstic i un tractament correctes d'aquesta malaltia, així com per establir el diagnòstic diferencial amb altres taquicàrdies ventriculars que presenten un pronòstic pitjor
Introducción: Las arritmias ventriculares en la edad pediátrica pueden presentar desde formas asintomáticas clínicas con extrasístoles ventriculares aisladas hasta formas con taquicardia ventricular sostenida con insuficiencia cardíaca y paro cardíaco. La taquicardia ventricular idiopática infantil es una de las entidades clínicas dentro de este grupo, con unas características clínicas y de pronóstico diferenciadas y con una evolución generalmente benigna. Observación clínica: Presentamos dos casos clínicos neonatales con taquicardia ventricular idiopática infantil. Ambos debutaron en forma de taquicardia ventricular bien tolerada hemodinámicamente, pero dada la frecuencia de aparición de los episodios se decidió iniciar tratamiento antiarrítmico con propranolol y posteriormente flecainida. En ambos casos, a las 24-48 horas de introducción de la flecainida se observa paso a ritmo sinusal y desaparición de los episodios de taquicardia ventricular. En el seguimiento posterior no se observa reaparición de episodios arrítmicos. Comentarios: El reconocimiento de las características clínicas y electrocardiográficas es esencial para la correcta valoración y tratamiento de esta enfermedad, así como para el diagnóstico diferencial con otras taquicardias ventriculares que presentan un peor pronóstico
Introduction: Ventricular arrhythmias in children can present in a wide range of clinical manifestations, varying from patients that are completely asymptomatic with isolated ventricular ectopic beats to more severe forms with sustained ventricular tachycardia, heart failure and cardiac arrest. Infantile idiopathic ventricular tachycardia is one of the clinical entities within this group with different clinical characteristics and prognosis and with a generally benign evolution. Clinical observation: We present two cases of neonatal presentation of infantile idiopathic ventricular tachycardia. Both cases presented in the form of hemodynamically tolerated ventricular tachycardia, but given the frequency of occurrence of the episodes a decision was made to initiate antiarrhythmic treatment with propranolol and subsequently flecainide. In both cases, sinus rhythm and disappearance of episodes of ventricular tachycardia were documented at 24-48 hours of introduction of flecainide. Both patients had a complete resolution, with no recurrence of arrhythmic episodes on subsequent follow-up. Comments: The prompt recognition of the clinical and electrocardiographic characteristics is essential for the correct assessment and treatment of this disease, as well as for the differential diagnosis with other ventricular tachycardias that carry a worse prognosis
